ID

26231

Descrizione

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Third party follow-up - Repeating form (Scheduled/Dynamic visit)

Keywords

versioni (3)
  1. 12/10/17 12/10/17 -
  2. 23/10/17 23/10/17 -
  3. 02/01/18 02/01/18 -
Titolare del copyright

GlaxoSmithKline

Caricato su

12 ottobre 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Third party follow-up GSK study Chronic Coronary Heart Disease NCT00799903

Inglese

Third party follow-up GSK study Chronic Coronary Heart Disease NCT00799903

1 moduli  
Date of last contact attempt
Descrizione

Date of last contact attempt

1. Date of most recent attempt to contact third party
Descrizione

Date of last contact attempt

Tipo di dati

date

Contact details
Descrizione

Contact details

2. Was contact successful? (i.e. actually spoke to someone)
Descrizione

contact successful

Tipo di dati

boolean

If contact successful: Type of third party contact
Descrizione

Type of third party contact

Tipo di dati

text

Other type of third party contact
Descrizione

Other type of third party contact

Tipo di dati

text

Are there any new study endpoints to report?
Descrizione

If Yes, complete SAE-EP and appropriate Endpoint forms.

Tipo di dati

text

Date endpoint information assessed by third party
Descrizione

Date endpoint information assessed by third party

Tipo di dati

date

Ritorna all'inizio della pagina

Similar models

Third party follow-up GSK study Chronic Coronary Heart Disease NCT00799903

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Date of last contact attempt
Date of last contact attempt
Item
1. Date of most recent attempt to contact third party
date
Item Group
Contact details
contact successful
Item
2. Was contact successful? (i.e. actually spoke to someone)
boolean
Item
If contact successful: Type of third party contact
text
Type of third party contact
Code List
If contact successful: Type of third party contact
CL Item
Investigative site staff (4)
CL Item
Health care provider other than investigative site staff (1)
CL Item
Family member (2)
CL Item
Friend or neighbor (5)
CL Item
Other (OT)
Other type of third party contact
Item
Other type of third party contact
text
Item
Are there any new study endpoints to report?
text
new study endpoints
Code List
Are there any new study endpoints to report?
CL Item
Unknown (Third party not able to find out if subject did or did not have new study endpoint, or the only information available is vital status "death" without details) (U)
CL Item
No (Third party able to confirm no new study endpoints) (N)
CL Item
Yes (Third party able to confirm the presence of new study endpoints. Do not select this option if the only information available is vital status "death" without details) (Y)
Date endpoint information assessed by third party
Item
Date endpoint information assessed by third party
date
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial